Home / Market Update / US Allows AstraZeneca to Resume Trials of Coronavirus Vaccine

US Allows AstraZeneca to Resume Trials of Coronavirus Vaccine

AstraZeneca said it has resumed trials in the United States of an experimental on Covid-19 vaccine after US regulatory approval.

On September 6, AstraZeneca suspended trials of its potential experimental coronavirus vaccine in the United States after a report that a participant in Britain’s trials had contracted a serious neurological disease believed to be transverse myelitis.

Check Also

German Joblessness Rises Above 3 Million as Economic Weakness Persists

Germany’s labor market showed renewed signs of strain in September, with unemployment rising more than …